Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Sales | 61,313 | 60,607 | 33,227 | 27,930 | 0 |
| Cost of Goods | 23,377 | 20,921 | 5,443 | 5,437 | N/A |
| Gross Profit | 37,936 | 39,686 | 27,785 | 22,494 | N/A |
| Operating Expenses | 40,002 | 27,499 | 18,607 | 13,714 | 1,644 |
| Operating Income | -1,689 | 13,108 | 9,620 | 9,216 | -1,644 |
| Interest Expense | 95 | 171 | 0 | 0 | 5 |
| Other Income | 0 | 0 | 1,175 | 22 | 1,827 |
| Pre-tax Income | -1,784 | 12,937 | 10,795 | 9,238 | 179 |
| Income Tax | -374 | 4,589 | 1,486 | 39 | 0 |
| Net Income Continuous | -1,410 | 8,348 | 9,309 | 9,199 | 179 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -716 |
| Minority Interests | N/A | N/A | N/A | -41 | N/A |
| Net Income | $-1,410 | $8,348 | $9,309 | $9,240 | $-538 |
| EPS Basic Total Ops | -0.50 | 3.50 | 4.00 | 4.40 | -1.40 |
| EPS Basic Continuous Ops | -0.50 | 3.48 | 3.98 | 4.40 | 0.40 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -1.80 |
| EPS Diluted Total Ops | -0.50 | 3.40 | 4.00 | 4.40 | -1.40 |
| EPS Diluted Continuous Ops | -0.50 | 3.41 | 3.98 | 4.40 | 0.40 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -1.80 |
| EPS Diluted Before Non-Recurring Items | -0.30 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $1,513 | $15,411 | $10,859 | $9,427 | $-1,641 |